Evidence map›Paper›PMID 38379517›Full record

ArticleThe European journal of neuroscience2024

An exploratory research report on brain mineralization in postoperative delirium and cognitive decline.

Florian Lammers-Lietz, Friedrich Borchers, Insa Feinkohl, Stefan Hetzer, Cicek Kanar, Frank Konietschke, Gunnar Lachmann, Claudia Chien, Claudia Spies, Georg Winterer and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The European journal of neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Florian Lammers-LietzDepartment of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-7371-3947
Friedrich BorchersDepartment of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-7290-2271
Insa FeinkohlMax-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin, Germany.ORCID 0000-0002-0307-1862
Stefan HetzerBerlin Center for Advanced Neuroimaging, Charité-Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-1773-1518
Cicek KanarDepartment of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0009-0004-9918-2998
Frank KonietschkeInstitute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Gunnar LachmannDepartment of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0003-2330-9839
Claudia ChienExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-8280-9513
Claudia SpiesDepartment of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-1062-0495
Georg WintererDepartment of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-3610-5029
Laszlo ZaborszkyCenter for Molecular and Behavioral Neuroscience, Rutgers University, Newark, New Jersey, USA.ORCID 0000-0002-8638-2921
Norman ZachariasDepartment of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.ORCID 0000-0001-5794-5716
Friedemann PaulExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-6378-0070
Humboldt-Universität zu Berlin · DEMax Delbrück Center · DEBernstein Center for Computational Neuroscience Berlin · DERutgers, The State University of New Jersey · USWitten/Herdecke University · DEZimmer Biomet (Germany) · DE

Funding

AFFERENT REGULATION OF CHOLINERGIC FOREBRAIN NEURONSR01NS023945 · NINDS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ZABORSZKY, LASZLO · 1986 to 2019
$6.5M
AFFERENT REGULATION OF CHOLINERGIC FOREBRAIN NEURONSRF1NS023945 · NINDS · RUTGERS THE STATE UNIV OF NJ NEWARK · PI ZABORSZKY, LASZLO · 2020 to 2020
$2.9M
Berlin Institute of Health Clinician Scientist ProgramCharité-Universitätsmedizin Berlin and the BIH at CharitéEuropean Commission 602461European Union Seventh Framework ProgramNINDS NIH HHS R01 NS023945NINDS NIH HHS RF1 NS023945
6 · The paper itself

Abstract

Delirium is a severe postoperative complication associated with poor overall and especially neurocognitive prognosis. Altered brain mineralization is found in neurodegenerative disorders but has not been studied in postoperative delirium and postoperative cognitive decline. We hypothesized that mineralization-related hypointensity in susceptibility-weighted magnetic resonance imaging (SWI) is associated with postoperative delirium and cognitive decline. In an exploratory, hypothesis-generating study, we analysed a subsample of cognitively healthy patients ≥65 years who underwent SWI before (N = 65) and 3 months after surgery (N = 33). We measured relative SWI intensities in the basal ganglia, hippocampus and posterior basal forebrain cholinergic system (pBFCS). A post hoc analysis of two pBFCS subregions (Ch4, Ch4p) was conducted. Patients were screened for delirium until the seventh postoperative day. Cognitive testing was performed before and 3 months after surgery. Fourteen patients developed delirium. After adjustment for age, sex, preoperative cognition and region volume, only pBFCS hypointensity was associated with delirium (regression coefficient [90% CI]: B = -15.3 [-31.6; -0.8]). After adjustments for surgery duration, age, sex and region volume, perioperative change in relative SWI intensities of the pBFCS was associated with cognitive decline 3 months after surgery at a trend level (B = 6.8 [-0.9; 14.1]), which was probably driven by a stronger association in subregion Ch4p (B = 9.3 [2.3; 16.2]). Brain mineralization, particularly in the cerebral cholinergic system, could be a pathomechanism in postoperative delirium and cognitive decline. Evidence from our studies is limited because of the small sample and a SWI dataset unfit for iron quantification, and the analyses presented here should be considered exploratory.

Indexed as

Cognitive DysfunctionDeliriumMagnetic Resonance ImagingPostoperative ComplicationsAgedAged, 80 and overBrainFemaleHumansMalePostoperative Cognitive Complicationsanaesthesiabasal nucleus of Meynertcholinergic systemdeliriummagnetic resonance imagingpostoperative cognitive dysfunctionsurgerysusceptibility weighted imaging

Identifiers

PMID38379517
PMCPMC11108748
OpenAlexW4392016787

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.